Management Of Low-Risk Polycythemia Vera

Management of Low-Risk Polycythemia Vera

The role of interferon in polycythemia vera & perspectives on the management of low-risk patients

VJHemOnc – Video Journal of Hematology & HemOnc

Treatment Options for Polycythemia Vera

Typical Treatment Plan for Polycythemia Vera Patients

The treatment of low and high-risk polycythemia vera

VJHemOnc – Video Journal of Hematology & HemOnc

Use of Cytoreductive Therapy in Patients with Low Risk Polycythemia Vera

International Academy for Clinical Hematology IACH

Polycythemia vera - causes, symptoms, diagnosis, treatment, pathology

Osmosis from Elsevier

New guidelines for the treatment and management of polycythemia vera

VJHemOnc – Video Journal of Hematology & HemOnc

The management of polycythemia vera with cytoreductive drug therapy

VJHemOnc – Video Journal of Hematology & HemOnc

How would you manage a young man with polycythemia vera and fatigue?

Management of Polycythemia Vera with Dr. Aaron Gerds

Blood Cancer Talks Podcast

The current treatment algorithm for polycythemia vera

VJHemOnc – Video Journal of Hematology & HemOnc

Prognostication and initiation of therapy in Polycythemia vera: Do we have it right?

Ropeginterferon Alfa-2b for the treatment of low-risk patients with polycythemia vera

Understanding High-Risk vs Low-Risk Disease in PV, ET & MF

Patient Empowerment Network

Current and emerging management strategies in polycythemia vera

VJHemOnc – Video Journal of Hematology & HemOnc

The need to improve diagnostic criteria in PV and other challenges in the field

VJHemOnc – Video Journal of Hematology & HemOnc

How does assessing risk in polycythemia vera (PV) help you design treatment plans?

LOW-PV interim analysis: Ropeginterferon versus phlebotomy in low-risk polycythemia vera

Ropeginterferon vs standard therapy for polycythemia vera

VJHemOnc – Video Journal of Hematology & HemOnc